on Onco-Innovations Limited (CVE:ONCO)
Onco-Innovations Subsidiary Files Provisional Patent for AI Platform SynoGraph
Onco-Innovations Limited's subsidiary, Inka Health, has filed a provisional patent application with the USPTO for its new AI platform, SynoGraph. This platform uses AI-driven causal inference to enhance precision medicine by identifying cancer patients likely to respond to treatments. The patent application, filed on January 28, 2025, is a significant step in safeguarding their innovative technology.
SynoGraph integrates diverse medical data like genomics and proteomics to optimize treatment decisions and clinical trial design. It aims to streamline trial design and patient selection, potentially shortening trial timelines and reducing development costs.
Dr. Paul Arora, CEO of Inka Health, emphasized the importance of protecting their AI technology to bolster their position in healthcare technology.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Onco-Innovations Limited news